Receptos (NASDAQ:RCPT) Director Amir Nashat sold 170,000 shares of the stock in a transaction dated Friday, December 6th. The shares were sold at an average price of $26.70, for a total transaction of $4,539,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Shares of Receptos (NASDAQ:RCPT) traded down 0.55% on Tuesday, hitting $27.26. The stock had a trading volume of 102,010 shares. Receptos has a 52 week low of $13.00 and a 52 week high of $35.26. The stock’s 50-day moving average is $25. and its 200-day moving average is $21.6.
Receptos (NASDAQ:RCPT) last issued its quarterly earnings data on Wednesday, October 30th. The company reported ($0.88) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.61) by $0.27. The company had revenue of $1.10 million for the quarter. Analysts expect that Receptos will post $-6.12 EPS for the current fiscal year.
A number of analysts have recently weighed in on RCPT shares. Analysts at Leerink Swann raised their price target on shares of Receptos to $45.00 in a research note to investors on Thursday, December 5th. Separately, analysts at Credit Suisse reiterated a “buy” rating on shares of Receptos in a research note to investors on Monday, November 18th. They now have a $31.00 price target on the stock. Finally, analysts at Wedbush raised their price target on shares of Receptos to $44.00 in a research note to investors on Monday, November 18th.
Receptos, Inc (NASDAQ:RCPT) is a biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.